Menu

Internal Medicine
Our MissionOur Team
CardiovascularDermatologicEndocrineENTGastrointestinalGenito-UrinaryHematologyImmunologyMusculoskeletalNeurologicOphthalmologyPsychiatricPulmonaryGLP-1 Medications
All Health ConditionsCardiovascularDermatologicEndocrineENTGastrointestinalGenito-UrinaryHematologyImmunologyMusculoskeletalNeurologicOphthalmologyPsychiatricPulmonary
Medication GuidePatient FormsYour First VisitPatient ResourcesLab VisitsSupplementsPatient PortalHIPAA PrivacyLocal VitalsFAQ
Outbreaks
Contact Us

Clopidogrel

Brand namesPlavix

Clopidogrel is an antiplatelet medication that prevents blood clots by keeping platelets from sticking together. It is used to reduce the risk of heart attack and stroke in people with cardiovascular disease.

Reviewed by Zimmer Medical GroupUpdated 8 min read
CardiovascularAntiplateletBlood ThinnersHeart Disease

About Clopidogrel

Clopidogrel is a p2y12 adp receptor antagonist (thienopyridine antiplatelet) also known by the brand name Plavix. It is primarily used to is prescribed to: • Prevent heart attack and stroke in people with atherosclerosis • Treat acute coronary syndrome (unstable angina or heart attack) • Prevent blood clots after recent heart attack or stroke • Reduce clotting risk after coronary stent placement • Peripheral artery disease • Prevent cardiovascular events in high risk patients Often used in combination with aspirin (dual antiplatelet therapy). Clopidogrel is available in oral tablet (75 mg, 300 mg) form. Healthcare providers commonly prescribe Clopidogrel for conditions including Hives (Urticaria), Osteoarthritis, Peptic Ulcer Disease, and Stroke.

Clopidogrel at a Glance

Brand names
Plavix
Drug class
P2Y12 ADP Receptor Antagonist (Thienopyridine Antiplatelet)
Pregnancy category
FDA Category Category B — Animal reproduction studies have not shown fetal harm, but human data are very limited. Use during pregnancy only when the maternal benefit clearly outweighs potential fetal risk, and discontinue at least 5 to 7 days before scheduled neuraxial anesthesia or delivery to reduce bleeding risk.
Available forms
Oral tablet (75 mg, 300 mg)
Therapeutic categories
Cardiovascular, Antiplatelet, Blood Thinners, Heart Disease
Conditions treated
5 related conditions on this site

What Clopidogrel Is Used For

is prescribed to:

• Prevent heart attack and stroke in people with atherosclerosis • Treat acute coronary syndrome (unstable angina or heart attack) • Prevent blood clots after recent heart attack or stroke • Reduce clotting risk after coronary stent placement • Peripheral artery disease • Prevent cardiovascular events in high-risk patients

Often used in combination with aspirin (dual antiplatelet therapy).

Dosage Quick Reference

These are general dosage guidelines for Clopidogrel. Your doctor will determine the appropriate dose for your specific situation.

ConditionStarting DoseMaintenance Dose
Acute coronary syndrome (NSTE-ACS, medically managed or PCI)300–600 mg loading dose75 mg once daily, typically for 12 months with aspirin
STEMI with PCI600 mg loading dose75 mg once daily for at least 12 months
Recent MI, recent stroke, or established PAD75 mg once daily (no loading dose required)75 mg once daily indefinitely per indication
Elective coronary stent (post-PCI maintenance)600 mg pre-procedure (per cath lab protocol)75 mg once daily for the duration recommended by cardiology

Side Effects

Common side effects may include:

• Easy bruising • Bleeding that takes longer to stop • Nosebleeds • Headache • Dizziness • Diarrhea or constipation • Stomach pain or indigestion

Serious side effects (seek immediate medical attention):

• Signs of severe bleeding (bloody or black stools, coughing up blood, severe bleeding that won't stop) • Stroke symptoms (sudden numbness, confusion, vision changes, severe headache) • Signs of TTP (fever, weakness, pale skin, purple spots on skin, yellowing of eyes/skin) • Unusual bruising or bleeding • Blood in urine • Chest pain • Allergic reactions

See also: Drug Interactions ↓

Drug Interactions

Clopidogrel is a prodrug that requires hepatic CYP2C19 activation to its active metabolite, so interactions with CYP2C19 and bleeding-risk medications dominate the profile.

  • Strong CYP2C19 inhibitors — omeprazole and esomeprazole: Reduce formation of the active metabolite and may diminish clopidogrel antiplatelet effect. The FDA recommends avoiding these PPIs; pantoprazole or H2 blockers such as famotidine are preferred when acid suppression is needed.
  • Anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran, heparin): Additive bleeding risk. Combination "triple therapy" should be limited in duration and used only when clearly indicated, with careful gastroprotection.
  • NSAIDs (ibuprofen, naproxen, ketorolac): Increase the risk of GI bleeding through additive antiplatelet effect and direct mucosal injury. Use the lowest effective NSAID dose for the shortest duration; consider acetaminophen alternatives.
  • SSRIs and SNRIs (e.g., sertraline, fluoxetine, venlafaxine): Modestly increase bleeding risk by impairing platelet serotonin uptake. Counsel patients on bruising and GI bleed signs; consider gastroprotection in higher-risk patients.
  • CYP2C19 genetic poor metabolizers: Although not a drug interaction per se, poor metabolizers form less active drug and may have higher cardiovascular event rates. Genotyping or alternative agents (prasugrel, ticagrelor) may be considered after stenting.

See also: Questions to Ask Your Doctor ↓

Key Considerations

Known drug interactions

Clopidogrel has documented interactions with other medications, supplements, and certain foods. Review the Drug Interactions section below and tell your healthcare provider about every medication you take, including over-the-counter products. Jump to section →

Additional Information

What is ?

Clopidogrel, widely known by its brand name Plavix, is an antiplatelet medication that plays a crucial role in preventing blood clots in people with cardiovascular disease. It is one of the most commonly prescribed medications for preventing heart attacks and strokes.

How Does Clopidogrel Work?

Clopidogrel is a prodrug that must be activated by the liver to work effectively. Once activated, it:

  • Irreversibly blocks P2Y12 receptors on platelets
  • Prevents platelets from sticking together (aggregation)
  • Reduces the formation of blood clots
  • Decreases the risk of clots blocking arteries
  • Works for the lifetime of the platelet (7-10 days)
  • Provides more potent antiplatelet effects than aspirin alone

Unlike aspirin, which blocks a different pathway, clopidogrel specifically targets ADP-mediated platelet activation, making it particularly effective when used alone or in combination with aspirin.

Common Uses

Clopidogrel is prescribed for several cardiovascular conditions:

  • Recent Heart Attack: Reduces risk of recurrent heart attack and death
  • Recent Stroke: Prevents secondary stroke
  • Peripheral Artery Disease (PAD): Reduces cardiovascular events in patients with PAD
  • Acute Coronary Syndrome: Used with aspirin in ACS treatment
  • Post-Stent Placement: Prevents clot formation on coronary stents (typically for 6-12 months or longer)
  • Stable Atherosclerotic Disease: Long-term prevention in established cardiovascular disease

Dosage and Administration

Clopidogrel is typically taken once daily:

  • Standard dose: 75 mg once daily
  • Loading dose: 300-600 mg for acute situations (ACS, PCI)
  • Can be taken with or without food
  • Take at the same time each day
  • Continue for the full prescribed duration
  • Do not stop without consulting your doctor

Dual Antiplatelet Therapy (DAPT): Often prescribed with aspirin (usually 81 mg daily) after stent placement or ACS. Duration depends on the clinical situation and stent type.

Important Safety Information

Who Should Not Take Clopidogrel?

Avoid clopidogrel if you have:

  • Active pathological bleeding (peptic ulcer, intracranial hemorrhage)
  • Known hypersensitivity to clopidogrel
  • Severe liver impairment

Use with caution if you have:

  • History of bleeding disorders
  • Recent surgery or trauma
  • Peptic ulcer disease
  • Conditions increasing bleeding risk

Drug Interactions

Proton Pump Inhibitors (PPIs):

  • Omeprazole and esomeprazole may reduce clopidogrel effectiveness
  • If PPI is needed, pantoprazole or H2 blockers may be preferred
  • Discuss with your doctor

Other important interactions:

  • NSAIDs (ibuprofen, naproxen) - increase bleeding risk
  • Warfarin or other anticoagulants - significantly increase bleeding risk
  • SSRIs/SNRIs - may increase bleeding risk
  • CYP2C19 inhibitors - may reduce effectiveness
  • Other antiplatelet agents - increase bleeding risk

Genetic Considerations

Approximately 2-14% of people (varies by ethnicity) have reduced-function CYP2C19 genetic variants that decrease clopidogrel's effectiveness. Genetic testing may be considered in certain situations, particularly after stent placement.

Poor metabolizers may:

  • Have reduced antiplatelet effects
  • Be at higher risk for stent thrombosis
  • Require alternative medications (ticagrelor, prasugrel)

Surgery and Procedures

Important considerations:

  • Clopidogrel increases bleeding risk during surgery
  • Generally stopped 5-7 days before elective surgery
  • Should NOT be stopped before cardiac surgery without cardiologist approval
  • Never stop abruptly after stent placement (risk of life-threatening stent thrombosis)
  • Inform all healthcare providers and dentists that you take clopidogrel
  • Carry a card or wear medical alert bracelet

Monitoring

While taking clopidogrel:

  • No routine blood monitoring required (unlike warfarin)
  • Watch for signs of bleeding
  • Report unusual bruising or bleeding
  • Monitor for effectiveness of therapy (prevention of cardiovascular events)
  • Platelet function testing may be done in select cases

Managing Bleeding Risk

To minimize bleeding risk while taking clopidogrel:

  • Use a soft toothbrush
  • Use electric razors instead of blades
  • Be careful with sharp objects
  • Avoid contact sports or activities with high injury risk
  • Report all medications and supplements to your doctor
  • Limit alcohol consumption
  • Apply pressure to cuts for longer than usual
  • Avoid NSAIDs unless specifically approved by your doctor

Lifestyle Considerations

While taking clopidogrel:

  • Follow a heart-healthy diet
  • Exercise regularly as recommended
  • Maintain healthy weight
  • Control blood pressure, cholesterol, and blood sugar
  • Don't smoke
  • Limit alcohol
  • Manage stress
  • Take medication consistently at the same time daily
  • Don't miss doses

When to Contact Your Doctor

Seek immediate medical attention if you experience:

  • Signs of serious bleeding (bloody or black stools, blood in urine, coughing up blood)
  • Bleeding that won't stop after applying pressure for 10 minutes
  • Severe or persistent nosebleeds
  • Unusual or severe bruising
  • Red or dark brown urine
  • Vomiting blood or material that looks like coffee grounds
  • Severe headache or dizziness
  • Chest pain or pressure
  • Signs of stroke (sudden weakness, vision changes, slurred speech, facial drooping)
  • Unexplained fever or weakness with purple spots on skin (possible TTP)

Contact your doctor for non-emergency issues:

  • Easy bruising
  • Frequent nosebleeds
  • Heavy menstrual periods
  • Scheduled surgery or dental work
  • New medications prescribed by another doctor
  • Stomach pain or indigestion

Duration of Treatment

Treatment duration varies:

  • After stent placement: Minimum 6-12 months, often longer for drug-eluting stents
  • After heart attack or stroke: Often long-term (indefinite)
  • Peripheral artery disease: Usually long-term
  • With aspirin (DAPT): Duration based on bleeding risk vs. thrombotic risk

Never stop clopidogrel without consulting your cardiologist, especially within the first year after stent placement.

Clinical Benefits

Studies have shown that clopidogrel:

  • Reduces risk of heart attack, stroke, and death in cardiovascular disease patients
  • Decreases stent thrombosis risk by more than 80% when used with aspirin
  • Reduces major cardiovascular events by approximately 20% compared to aspirin alone in certain populations
  • Improves outcomes in acute coronary syndrome
  • Reduces cardiovascular events in peripheral artery disease

Storage

Store clopidogrel at room temperature (77°F/25°C) away from moisture and heat. Keep in original container. Keep out of reach of children.

Disclaimer: This information is for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult your physician or other qualified healthcare provider with any questions about a medical condition or medication.

Frequently Asked Questions

Duration depends on the stent type and clinical setting. After a drug-eluting stent for acute coronary syndrome, current guidelines typically recommend at least 12 months of dual antiplatelet therapy with aspirin, with shorter or longer durations individualized based on bleeding and ischemic risk. Never stop clopidogrel after a stent without first discussing it with your cardiologist.
For minor dental work and many simple skin procedures, clopidogrel can usually be continued. For most major surgeries, clopidogrel is held for 5 to 7 days beforehand to allow platelet function to recover. The decision must be individualized — never stop the medication on your own. Always tell every surgeon and dentist that you take an antiplatelet drug.
Omeprazole and esomeprazole strongly inhibit the CYP2C19 enzyme that converts clopidogrel to its active form, potentially weakening its antiplatelet effect. The FDA recommends choosing a different acid-reducing strategy when possible — pantoprazole or H2 blockers such as famotidine are reasonable alternatives that do not significantly affect clopidogrel activation.
Seek prompt evaluation for black or tarry stools, bright red blood in the stool or vomit, blood in the urine, severe or unexplained bruising, nosebleeds that will not stop, or sudden severe headache. Minor gum bleeding when brushing or occasional small bruises are common and usually do not require urgent attention.
Yes — and the combination, called dual antiplatelet therapy, is the standard of care after acute coronary syndromes and coronary stenting. The two drugs block different parts of the platelet activation pathway. Do not combine them unless your cardiologist has specifically prescribed both, and use the lowest effective aspirin dose (usually 81 mg) to limit bleeding.

Questions to Ask Your Doctor About Clopidogrel

Consider discussing these topics at your next appointment:

  • How long should I stay on clopidogrel, and what determines that timeline?
  • Should I be tested for CYP2C19 poor metabolizer status, especially after a stent?
  • Is my acid-reducing medication compatible with clopidogrel?
  • What is my bleeding risk score, and should I be on a stomach-protecting medication?
  • What over-the-counter pain medications are safe for me while on clopidogrel?
Schedule an Appointment

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.